Morningstar

Buffalo High Yield Fund Institutional Class BUIHX

Morningstar Medalist Rating
Medalist Rating as of | See Buffalo Investment Hub
  • NAV / 1-Day Return 10.40  /  +0.10 %
  • Total Assets 646.7M
  • Adj. Expense Ratio
    0.870%
  • Expense Ratio 0.860%
  • Distribution Fee Level High
  • Share Class Type Institutional
  • Category High Yield Bond
  • Credit Quality / Interest Rate Sensitivity Low/Limited
  • Min. Initial Investment 250,000
  • Status Open
  • TTM Yield 7.26%
  • Effective Duration 1.56 years

USD | NAV as of Jul 10, 2026 | 1-Day Return as of Jul 10, 2026, 12:23 AM GMT+0

Morningstar’s Analysis BUIHX

Will BUIHX outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

  • Process Pillar

    The Process Pillar is our assessment of how sensible, clearly defined, and repeatable BUIHX’s performance objective and investment process is for both security selection and portfolio construction.

  • People Pillar

    The People Pillar is our evaluation of the BUIHX management team’s experience and ability. We find that high-quality management teams deliver superior performance relative to their benchmarks and/or peers.

  • Parent Pillar

    The Parent Pillar is our rating of BUIHX’s parent organization’s priorities and whether they’re in line with investors’ interests.

null Morningstar Automated Analysis

Morningstar Automated Analysis

Summary

Buffalo High Yield Institutional holds a quantitatively derived Negative Morningstar Medalist Rating. The rating indicates the model sees limited potential for the strategy to outperform peers on a risk-adjusted basis over a full market cycle.

by Morningstar Automated Analysis
Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings BUIHX

More BUIHX Holdings
  • Current Portfolio Date
  • Equity Holdings —
  • Bond Holdings —
  • Other Holdings —
  • % Assets in Top 10 Holdings 17.0
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Fidelity Inv MM Government I

5.78 38M
Cash and Equivalents

Amneal Pharmaceuticals 1/26

2.30 15M
Corporate

Harrow Inc 8.63%

2.16 14M
Corporate

Grupo Aeromexico S. A. B. De C. V. 8.63%

2.06 13M
Corporate

Ardonagh Group Finance Ltd. 8.88%

1.79 12M
Corporate

Verde Purchaser Llc

1.77 12M
Corporate

Saturn Oil & Gas Inc 9.63%

1.66 11M
Corporate

Endo Finance Holdings T/L B (Endo Pharmaceuticals)

1.50 10M
Corporate

Nexus Buyer (Promontory Interfinancial/IntraFi Network) T/L B (1/25)

1.28 8M
Corporate

Provident Funding Associates LP / PFG Finance Corp 9.75%

1.25 8M
Corporate

Sponsor Center